As miltirone was predicted to enhance the sensitivity of GC cells to cisplatin via modulation of the PI3K/AKT signaling pathway, we investigated possible binding of miltirone to key proteins of the PI3K/AKT signaling pathway. Here, AKT1 is linked to gastric cancer.